Eli Lilly to spend $27 billion to bolster U.S. drug manufacturing as Trump tariffs loom
The push to onshore manufacturing was already underway at Lilly, which has been investing heavily to boost production capacity for Zepbound and Mounjaro.

Apr 4, 2025 0
Apr 3, 2025 0
Or register with email
Feb 19, 2025 0
Mar 22, 2025 0
Mar 23, 2025 0
Feb 19, 2025 0
Feb 21, 2025 0
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.